A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

计划入组 170 人 · 首次发布于 2024 年 11 月 7 日

Adequacy of Haemodiafiltration: Middle Molecules Clearance, Patients Reported Outcomes and Sodium Balance

计划入组 300 人 · 首次发布于 2026 年 7 月 21 日

REC-7735 in Participants With Solid Tumors

计划入组 90 人 · 首次发布于 2026 年 9 月 14 日

REC-163964

REC-0000355

REC-467

Christian Schulze

Germany

Recombio SL

Spain

Reconnect Labs

Switzerland

Recursion Pharmaceuticals Doses First Patient in Phase 2 Study of REC-3964 for Recurrent C. diff Infection

Recursion's Oncology Drugs REC-3565 and REC-4539 Advance to Clinical Trials

Recursion Doses First Patient in Phase 2 Trial of REC-3964 for Recurrent C. difficile Infection